Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Luigi Ferrarini

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|October 4, 2002
Synthesis of variously substituted 1,8-naphthyridine derivatives and evaluation of their antimycobacterial activityMuwaffag Badawneh, Clementina Manera, Claudio Mori, et al.
Journal of Medicinal Chemistry|February 3, 2006
Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysisTiziano Tuccinardi, Pier Luigi Ferrarini, Clementina Manera, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Synthesis of 3- or 4-phenyl-1,8-naphthyridine derivatives and evaluation of antimycobacterial and antimicrobial activityMuwaffag Badawneh, Laura Bellini, Tiziana Cavallini, et al.
Bioorganic & Medicinal Chemistry|March 31, 2004
Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptorsPier Luigi Ferrarini, Vincenzo Calderone, Tiziana Cavallini, et al.
Bioorganic & Medicinal Chemistry|November 8, 2003
Synthesis and beta-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]pyridine: identification of beta 3-antagonistsGiuseppe Saccomanni, Muwaffag Badawneh, Barbara Adinolfi, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2005
1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptorsClementina Manera, Laura Betti, Tiziana Cavallini, et al.
Journal of Medicinal Chemistry|May 28, 2004
Study on affinity profile toward native human and bovine adenosine receptors of a series of 1,8-naphthyridine derivativesPier Luigi Ferrarini, Laura Betti, Tiziana Cavallini, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 8, 2002
4-[6-(Dansylamino)hexylamino]-7-methyl-2-phenyl-1,8-naphthyridine as a new potential fluorescent probe for studying A1-adenosine receptorMarco Macchia, Simone Bertini, Valeria Di Bussolo, et al.
Journal of Medicinal Chemistry|September 29, 2006
Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonistsClementina Manera, Veronica Benetti, M Paola Castelli, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2007
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonistsClementina Manera, Maria Grazia Cascio, Veronica Benetti, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Farmaco (Societa Chimica Italiana : 1989)|October 4, 2002
Synthesis of variously substituted 1,8-naphthyridine derivatives and evaluation of their antimycobacterial activityMuwaffag Badawneh, Clementina Manera, Claudio Mori, et al.
Journal of Medicinal Chemistry|February 3, 2006
Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysisTiziano Tuccinardi, Pier Luigi Ferrarini, Clementina Manera, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Synthesis of 3- or 4-phenyl-1,8-naphthyridine derivatives and evaluation of antimycobacterial and antimicrobial activityMuwaffag Badawneh, Laura Bellini, Tiziana Cavallini, et al.
Bioorganic & Medicinal Chemistry|March 31, 2004
Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptorsPier Luigi Ferrarini, Vincenzo Calderone, Tiziana Cavallini, et al.
Bioorganic & Medicinal Chemistry|November 8, 2003
Synthesis and beta-blocking activity of (R,S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]pyridine: identification of beta 3-antagonistsGiuseppe Saccomanni, Muwaffag Badawneh, Barbara Adinolfi, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2005
1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptorsClementina Manera, Laura Betti, Tiziana Cavallini, et al.
Journal of Medicinal Chemistry|May 28, 2004
Study on affinity profile toward native human and bovine adenosine receptors of a series of 1,8-naphthyridine derivativesPier Luigi Ferrarini, Laura Betti, Tiziana Cavallini, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 8, 2002
4-[6-(Dansylamino)hexylamino]-7-methyl-2-phenyl-1,8-naphthyridine as a new potential fluorescent probe for studying A1-adenosine receptorMarco Macchia, Simone Bertini, Valeria Di Bussolo, et al.
Journal of Medicinal Chemistry|September 29, 2006
Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonistsClementina Manera, Veronica Benetti, M Paola Castelli, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2007
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonistsClementina Manera, Maria Grazia Cascio, Veronica Benetti, et al.
Pageof 2